07/31/2026
๐ก ๐๐ฏ๐๐ซ๐ฒ ๐ฌ๐๐ข๐๐ง๐ญ๐ข๐๐ข๐ ๐ซ๐๐ฏ๐จ๐ฅ๐ฎ๐ญ๐ข๐จ๐ง ๐๐๐ ๐ข๐ง๐ฌ ๐ฐ๐ข๐ญ๐ก ๐ฌ๐จ๐ฆ๐๐จ๐ง๐ ๐ฎ๐ง๐ฐ๐ข๐ฅ๐ฅ๐ข๐ง๐ ๐ญ๐จ ๐ฌ๐ญ๐จ๐ฉ ๐๐ฌ๐ค๐ข๐ง๐ ๐จ๐ง๐ ๐ช๐ฎ๐๐ฌ๐ญ๐ข๐จ๐ง: ๐๐ก๐ฒ?
As a child, ๐๐ซ๐ข๐๐ง ๐๐ซ๐ฎ๐ค๐๐ซ took apart clocks to understand how they worked. Decades later, the same curiosity led him to challenge how cancer itself could be treatedโhelping pave the way for ๐ข๐ฆ๐๐ญ๐ข๐ง๐ข๐ and the era of targeted therapy.
Twenty-five years after one of oncologyโs defining breakthroughs, Dr. Druker reflects on the curiosity, setbacks, and patients who shaped a discovery that transformed the lives of people with chronic myeloid leukaemia.
Itโs a reminder that behind every breakthrough is not only great science, but the people courageous enough to question what everyone else accepts.
๐ Read the full interview by ๐๐ฅ๐๐ค๐ฌ๐๐ง๐๐ซ๐ ๐
๐ข๐ฅ๐ข๐ฉ๐จ๐ฏ๐ข๐ MD Ph.D.: https://lnkd.in/eUQWY-UJ
OncoDaily | Oregon Health & Science University (OHSU) | OHSU Knight Cancer Institute
hashtag hashtag hashtag hashtag hashtag hashtag